Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. News
  4. >
  5. Marex Group Faces Class Action for Misleading Statements; Investors May Claim Losses

Marex Group Faces Class Action for Misleading Statements; Investors May Claim Losses

Written by Emily J. Thompson, Senior Investment Analyst
stocks logo
MRX.O-0.19%
Source: Globenewswire
Updated: 1 hour ago
0mins
Intellectia AI SwingMax
Intellectia AI SwingMax
Source: Globenewswire
  • Lawsuit Initiation: Bragar Eagel & Squire has filed a class action lawsuit against Marex Group in the Southern District of New York on behalf of investors who purchased securities between May 16, 2024, and August 5, 2025, indicating significant legal risks for the company.
  • False Statement Allegations: The complaint alleges that Marex made materially false and misleading statements during this period, failing to disclose inconsistencies in its financial statements, which misled investors regarding the company's prospects and could undermine shareholder confidence.
  • Investor Rights Protection: Investors must apply by December 8, 2025, to be appointed as lead plaintiffs in the lawsuit, indicating that the legal proceedings may provide a pathway for affected investors to claim losses, potentially impacting the company's future stock performance.
  • Legal Consultation Channels: Affected investors can contact the law firm via phone or email to learn more and participate in the lawsuit, indicating that legal support will provide necessary assistance to protect their rights.
stocks logo
MRX.O
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
no data image
No Data
Powered By
Intellectia
Analyst Views on MRX
Wall Street analysts forecast MRX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MRX is 50.60 USD with a low forecast of 43.00 USD and a high forecast of 58.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast MRX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MRX is 50.60 USD with a low forecast of 43.00 USD and a high forecast of 58.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 37.540
sliders
Low
43.00
Averages
50.60
High
58.00
Current: 37.540
sliders
Low
43.00
Averages
50.60
High
58.00
Keefe Bruyette
Kyle Voigt
Outperform
maintain
$49 -> $50
2025-11-07
Reason
Keefe Bruyette
Kyle Voigt
Price Target
$49 -> $50
2025-11-07
maintain
Outperform
Reason
Keefe Bruyette analyst Kyle Voigt raised the firm's price target on Marex Group to $50 from $49 and keeps an Outperform rating on the shares.
Barclays
NULL -> Overweight
maintain
$40 -> $43
2025-11-07
Reason
Barclays
Price Target
$40 -> $43
2025-11-07
maintain
NULL -> Overweight
Reason
Barclays raised the firm's price target on Marex Group to $43 from $40 and keeps an Overweight rating on the shares. The company reported a solid Q3, the analyst tells investors in a research note.
Barclays
Overweight
downgrade
$52 -> $50
2025-08-14
Reason
Barclays
Price Target
$52 -> $50
2025-08-14
downgrade
Overweight
Reason
Barclays lowered the firm's price target on Marex Group to $50 from $52 and keeps an Overweight rating on the shares following the Q2 report. The company reported an earnings beat and its sales momentum continued into July, the analyst tells investors in a research note. The firm believes Marex also provided a strong rebuttal to a recent short report, answering many key questions.
Barclays
Benjamin Budish
Overweight
downgrade
$57 -> $52
2025-06-09
Reason
Barclays
Benjamin Budish
Price Target
$57 -> $52
2025-06-09
downgrade
Overweight
Reason
Barclays analyst Benjamin Budish lowered the firm's price target on Marex Group to $52 from $57 and keeps an Overweight rating on the shares.
See All Ratings
AI Stock Picker
AI Stock Picker
About MRX
Marex Group plc offers a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. Its segments include Clearing, Agency and Execution, Market Making, Hedging and Investment Solutions, and Corporate. The Clearing segment acts as the interface between exchanges and clients. This segment provides the connectivity that allows its clients access to exchanges and central clearing houses. The Agency and Execution segment matches buyers and sellers on an agency basis by facilitating price discovery primarily across energy and financial securities markets. Market Making segment acts as principal to provide direct market pricing to professional and wholesale counterparties, primarily metals, agriculture, energy, and financial securities markets. The Company also owns an equity market maker Winterflood Securities.

About the author

Emily J. Thompson
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Top News

SpaceX Targets $800 Billion Valuation in Secondary Sale

06 Dec 25
news image

U.S. Consumer Sentiment Slightly Improves in December

06 Dec 25
news image

U.S. Consumer Spending Slows in September

06 Dec 25
news image

Netflix Acquires Warner Bros. Assets in $72B Deal

05 Dec 25
news image

Related Articles

Ascentage Pharma's Lisaftoclax Shows 62.5% ORR in BTK-Refractory CLL/SLL Patients

00:13 AM
news image

Prelude Therapeutics Unveils JAK2 Inhibitor with IND Filing Expected in Q1 2026

00:13 AM
news image

Sigh Up to Get Intellectia Insights

arrow icon

What is the strategic significance of Marex acquiring Winterflood Securities?

arrow icon

Why are investors encouraged to apply for lead plaintiff status by December 8, 2025?

arrow icon

How might Marex's stock price change after the class action lawsuit progresses?

arrow icon

What impact could the sale of Winterflood's custody business have on Marex's profitability?

arrow icon

How do the allegations of financial fraud affect Marex's market reputation?

People Also Watch

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free